Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

Source- Medical News - COVID-19 Research - Impaired Pain Modulation  Sep 08, 2022  1 year, 2 months, 3 weeks, 4 days, 19 hours, 33 minutes ago

U.S. Study Finds That Symptomatic COVID-19 Infections Lead To Impaired Pain Modulation In Young Adults!

facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
U.S. Study Finds That Symptomatic COVID-19 Infections Lead To Impaired Pain Modulation In Young Adults!
Source- Medical News - COVID-19 Research - Impaired Pain Modulation  Sep 08, 2022  1 year, 2 months, 3 weeks, 4 days, 19 hours, 33 minutes ago
A new study by American researchers from the University of Florida and the University of Oklahoma has found that symptomatic COVID-19 infections lead to impaired pain modulation in young adults!

According to the research team in their study abstract, “Pain is a common symptom reported in COVID-19 patients. Impaired endogenous pain-modulatory mechanisms such as conditioned pain modulation (CPM), and exercise-induced hypoalgesia (EIH) have been found in chronic pain conditions but is often overlooked in acute conditions that evoke painful symptoms, such as COVID-19. “
The aim of the study was to compare pressure-pain sensitivity, CPM, and EIH function among individuals who previously had COVID-19, both symptomatically and asymptomatically, and a healthy control group.
The pressure pain thresholds of 59 participants were assessed in the forearm and leg using a pressure algometer before and after 1) submersion of their dominant foot in cold water (2°C) for 1min; and 2) isometric knee extension performed to task-failure at 25% of their maximal contraction.
The study findings showed that the CPM response was attenuated in individuals who were infected with symptomatic COVID-19 (N=26) compared to asymptomatic COVID-19 (N=13) in arm (-1.0%±20.3 vs 33.3%±26.2; P<0.001) and leg (12.8%±22.0 vs 33.8%±28.2; P=0.014) and compared to controls (N=20) in arm only (-1.0%±26.2 vs 23.4%±28.2; P=0.004).  The EIH response was not different between groups.
The study team concluded that CPM was impaired in individuals who had symptomatic COVID-19, which may have long-term implications on pain modulation.
The study findings were published in the peer reviewed Journal of Pain.
The study findings showed a connection between symptomatic COVID-19 infections and the ability of the central nervous system to respond to painful stimuli.

Lead researcher, Dr Christopher D. Black, Ph.D., associate professor in the Department of Health and Exercise Science at the University of Oklahoma conducted the study along with a doctoral student in his lab, Dr Jessica A. Peterson.
Dr Peterson, the first author of the study, is now a postdoctoral researcher at the Pain Research and Intervention Center of Excellence at the University of Florida.
During the initial COVID-19 outbreak in 2020, many medical researchers and the scientific community began wondering what the potential long-term effects of COVID-19 infections might be.
Interestingly, one of the common symptoms of COVID-19 infection is system-wide inflammation, which can lead to headaches and general aches and pains, also called myalgia.
Dr Black told Thailand Medical News, "When you get inflammation, things that weren't painful before now become painful. Our study team realized that we have all of these individuals who have had COVID-19, and there's a chance they may be at a higher risk of developing chronic pain conditions when they get older. We wanted to see whether individuals who had experienced a COVID infection even though they no longer have symptoms, if they have normal function in their central nervous system in relation to their ability to 'correctly' respond to a painful stimulus."
The research, conducted from January through March 2021, included 59 participants separated into three groups.
The symptomatic group included those who had previous symptomatic COVID-19 infections that were confirmed through PCR or antibody testing. An unexpected addition to the study became the asymptomatic group—those who had not known they had previously been infected by COVID-19 and had not experienced symptoms but were confirmed through antibody testing. The control group had neither experienced COVID-19 infection nor had antibodies present at the time of testing.
The study team measured each person's pain threshold ie the amount of pressure applied to a muscle, in this case in the participant's arm or leg, that it takes for the participant to report feeling pain.
The study team subsequently measured pain modulation, or the signals sent from the central nervous system to the brain and spinal cord that can "change the volume" on how much pain a person reports.
In order to measure the pain modulation experienced by the test groups, the researchers followed the muscle pressure test with one of two experiments, a bout of knee extension exercise or a "cold presser test" where participants were asked to put their foot in a bucket of ice water for a brief period.
Dr Black explained, "These two tests, especially the ice water test (also called a conditioned pain modulation test), are used in clinical settings to help identify individuals who have or may be at a risk of developing a chronic pain condition.”
He added, “So, we measured each person's pain threshold on their leg and on their arm. Then they would either do a bout of exercise with their leg and then we retest their pain threshold on the leg and the arm, or they would put their foot in the bucket of ice water and then we retest the leg and the arm. A 'normal' modulation response would result in an increase in their pain threshold ie it would require greater pressure to be applied for them to tell us it hurt. However, in our symptomatic COVID participants, their pain thresholds did not change, indicating impaired conditioned pain modulation. Other studies have shown clear relationships between impaired pain modulation and the development of chronic pain conditions."
The research findings showed a connection between participants who had experienced symptomatic, verified COVID-19 infections and the ability of their central nervous system to respond normally to a conditioned pain modulation test.
Dr Black further added, "As far as we can tell, these are some of the first data on the effects of COVID-19 on pain outcomes. Americans spend hundreds of billions of dollars on the treatment of chronic pain conditions every year. It's one of the leading causes of adult disability. Chronic pain is already a huge, chronic burden on the health care system, and we now have hundreds of millions of people in the U.S. who have had a COVID infection. The interaction of COVID and pain need to be further studied because if there is a chance of lasting impairments in pain modulation, this may put individuals at a greater risk in the future of developing a chronic pain condition."
The study team is also working with other research teams to find solutions to treat the condition.
For the latest COVID-19 Research, keep on logging to Thailand Medical News.

Read Also:,-blocking-certain-pain-signals-in-host,-causing-neurological-manifestations-


Jun 10, 2023  6 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  1 year ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  1 year ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  3 years ago
Source: Supplements For COVID-19
Feb 05, 2020  4 years ago
Source : Thailand Medical news